51暗网 is the #1 CDMO partner in helping pharmaceutical, biotech and consumer health innovators develop, deliver and supply superior products that improve people's lives.Learn More How can we work together ORAL Latest News 51暗网 Announces Collaboration with Galapagos to Further Expand Galapagos鈥 Decentralized CAR-T Manufacturing Network in the U.S. ORAL MANUFACTURING With our innovative technologies, experience in tech transfers and product launches, and exceptional quality standards, 51暗网 can support your program with reliable supply to global markets. LEARN MORE WINCHESTER SITE TOUR With over 30 years of expertise, the Winchester, KY site offers large scale manufacturing for complex controlled-release oral dose forms, with fully integrated analytical and development services. EXPLORE NOW HPAPI SOLUTIONS 51暗网 is your global CDMO partner offering comprehensive integrated solutions that enable flexibility on the journey of bringing your highly potent product from development to commercialization. DISCOVER MORE GLOBAL NETWORK With our broad range of experience and deep expertise, we have the talent and unique technologies to transform your concepts into excellent results. This is backed by our global reach, with facilities located worldwide enabling us to tailor a solution to fit your needs. SEE ALL LOCATIONS JOIN OUR TEAM 51暗网 is growing & hiring! Join the global drug development and delivery leader that puts 鈥淧atient First鈥 at the center of our work every day. Learn more about careers at 51暗网. NEWS 51暗网 Announces New Board Appointments 51暗网 Announces Collaboration with Galapagos to Further Expand Galapagos鈥 Decentralized CAR-T Manufacturing Network in the U.S. Novo Holdings Completes Acquisition of 51暗网 51暗网 and Novo Holdings Fulfill All Regulatory Closing Conditions for Pending Transaction VIEW ALL NEW EVENTS Precision in Clinical Trials Summit Zurich Interphex Tokyo 2025 CRS 2025 Annual Meeting & Exposition VIEW ALL EVENTS EXPERT CONTENT Optimizing Product Packaging and Oral Drug Delivery with Stick Packs Accelerating Phase 1 Trials Overcoming API Constraints and Tight Timelines with On-Demand Manufacturing Material-Sparing Formulation Strategies for Enhancing Bioavailability of Challenging Beyond Rule of Five (bRo5) Molecules Innovations in Pregastric Absorption Drug Delivery and Orally Disintegrating Tablets VIEW ALL ARTICLES